icon-folder.gif   Conference Reports for NATAP  
 
  ID Week
October 2-6, 2013
San Francisco
Back grey_arrow_rt.gif
 
 
 
Metabolic, Bone, Renal, Inflammatory and Lipodystrophic Marker Analysis in INROADS, a Multicenter, Single-Arm, Open-Label Study of a Once-Daily Nucleoside/tide-Sparing Regimen of Etravirine (ETR) and Darunavir/Ritonavir (DRV/r) as Dual Therapy in Early Treatment-Experienced Subjects
 
 
  Reported by Jules Levin
IDSA 2013 Oct 2-6 San Francisco, CA
 
Moti Ramgopal,1 Fritz Bredeek,2 Joseph Gathe,3 Robert Ryan,4 Bruce Coate,4 David Anderson5
1Midway Immunology and Research Center, Ft. Pierce, Florida, USA; 2Metropolis Medical, San Francisco, California, USA; 3Therapeutic Concepts, Houston, Texas, USA; 4Janssen Research & Development, Titusville, New Jersey, USA; 5Janssen Services, LLC, Titusville, New Jersey, USA

ID1.gif

ID2.gif

ID3.gif

ID4.gif

ID5.gif

ID6.gif

ID7.gif

ID8.gif

ID9.gif

ID10.gif

ID11.gif

ID12.gif

ID13.gif

ID14.gif

ID15.gif

ID16.gif

ID17.gif

ID18.gif

ID19.gif